User profiles for Dana Craiu
Craiu DanaProfessor, Carol Davila University of Medicine, Alexandru Obregia Hospital Verified email at umfcd.ro Cited by 3692 |
Summary of recommendations for the management of infantile seizures: Task f orce r eport for the ilae c ommission of p ediatrics
Evidence‐based guidelines, or recommendations, for the management of infants with
seizures are lacking. A Task Force of the Commission of Pediatrics developed a consensus …
seizures are lacking. A Task Force of the Commission of Pediatrics developed a consensus …
[PDF][PDF] De novo mutations in synaptic transmission genes including DNM1 cause epileptic encephalopathies
Emerging evidence indicates that epileptic encephalopathies are genetically highly
heterogeneous, underscoring the need for large cohorts of well-characterized individuals to further …
heterogeneous, underscoring the need for large cohorts of well-characterized individuals to further …
De novo loss-or gain-of-function mutations in KCNA2 cause epileptic encephalopathy
…, T Linnankivi, AE Lehesjoki, K Sterbova, DC Craiu… - Nature …, 2015 - nature.com
Epileptic encephalopathies are a phenotypically and genetically heterogeneous group of
severe epilepsies accompanied by intellectual disability and other neurodevelopmental …
severe epilepsies accompanied by intellectual disability and other neurodevelopmental …
The phenotypic spectrum of SCN8A encephalopathy
Objective: SCN8A encodes the sodium channel voltage-gated α8-subunit (Na v 1.6). SCN8A
mutations have recently been associated with epilepsy and neurodevelopmental disorders. …
mutations have recently been associated with epilepsy and neurodevelopmental disorders. …
[PDF][PDF] De novo loss-of-function mutations in CHD2 cause a fever-sensitive myoclonic epileptic encephalopathy sharing features with Dravet syndrome
…, A Kecskés, Y Weber, S Weckhuysen, DC Craiu… - The American Journal of …, 2013 - cell.com
Dravet syndrome is a severe epilepsy syndrome characterized by infantile onset of therapy-resistant,
fever-sensitive seizures followed by cognitive decline. Mutations in SCN1A explain …
fever-sensitive seizures followed by cognitive decline. Mutations in SCN1A explain …
De novo variants in neurodevelopmental disorders with epilepsy
…, H Stamberger, R Abou Jamra, H Caglayan, D Craiu… - Nature …, 2018 - nature.com
Epilepsy is a frequent feature of neurodevelopmental disorders (NDDs), but little is known
about genetic differences between NDDs with and without epilepsy. We analyzed de novo …
about genetic differences between NDDs with and without epilepsy. We analyzed de novo …
Phenotypic spectrum of GABRA1 From generalized epilepsies to severe epileptic encephalopathies
Objective: To delineate phenotypic heterogeneity, we describe the clinical features of a cohort
of patients with GABRA1 gene mutations. Methods: Patients with GABRA1 mutations were …
of patients with GABRA1 gene mutations. Methods: Patients with GABRA1 mutations were …
Co‐occurring malformations of cortical development and SCN1A gene mutations
Objective To report on six patients with SCN 1A mutations and malformations of cortical
development ( MCD s) and describe their clinical course, genetic findings, and electrographic, …
development ( MCD s) and describe their clinical course, genetic findings, and electrographic, …
CHD2 myoclonic encephalopathy is frequently associated with self-induced seizures
Objective: To delineate the phenotype of early childhood epileptic encephalopathy due to de
novo mutations of CHD2, which encodes the chromodomain helicase DNA binding protein …
novo mutations of CHD2, which encodes the chromodomain helicase DNA binding protein …
Mapping the differences in care for 5,000 spinal muscular atrophy patients, a survey of 24 national registries in North America, Australasia and Europe
…, V Guergueltcheva, N Butoianu, D Craiu… - Journal of …, 2014 - Springer
Spinal muscular atrophy (SMA) is an autosomal recessive genetic disorder characterised by
the degeneration of motor neurons and progressive muscle weakness. It is caused by …
the degeneration of motor neurons and progressive muscle weakness. It is caused by …